The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference
about
Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and RecommendationsHealth-Related Quality of Life of the General German Population in 2015: Results from the EQ-5D-5LHand grip strength and chronic obstructive pulmonary disease in Korea: an analysis in KNHANES VI.Sample size determination for EQ-5D-5L value set studies.Predicting EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) Utilities from Older People's Quality of Life Brief Questionnaire (OPQoL-Brief) Scores.A Comparison of the Validity and Responsiveness of the EQ-5D-5L and SF-6D for Measuring Health Spillovers: A Study of the Family Impact of Meningitis.Is quality of life different between diabetic and non-diabetic people? The importance of cardiovascular risks.Predictors of self-reported health-related quality of life according to the EQ-5D-Y in chronically ill children and adolescents with asthma, diabetes, and juvenile arthritis: longitudinal results.Improvement in health-related quality of life after renal sympathetic denervation in real-world hypertensive patients: 12-month outcomes in the Global SYMPLICITY Registry.Responsiveness of the EuroQoL 5-dimension (EQ-5D) in adolescent idiopathic scoliosis.Comparison of health state values derived from patients and individuals from the general population.An intervention for pulmonary rehabilitators to develop a social identity for patients attending exercise rehabilitation: a feasibility and pilot randomised control trial protocol.Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study).Clinical characteristics and related risk factors of depression in patients with early COPD.Valuing health-related quality of life: systematic variation in health perception
P2860
Q30245662-65FD6729-0AD5-489A-AD90-5D5551A74FD3Q33616369-F318CCF1-CE57-4803-A123-3472B27991C5Q38613242-08BD972A-EC2E-4BD2-A6B8-0AE3379F6D6AQ38616456-D6FF6F4F-36B4-4D2F-9427-ED0B13B324C1Q38721552-261AF9BB-0C07-467A-ACD3-7A358A328260Q38774305-509ADC88-2ED9-4562-B37B-5191D2991772Q47155245-0262F6B4-2DBE-410D-B9A5-FD16E12AD41FQ47391755-FB7BF329-BE42-4224-ADF7-0E636D063AE7Q47894290-67D65F03-9365-4E52-89F7-1880FA2B1B9EQ48219008-0E0E1B77-79F6-44C7-B424-22719249209BQ48238595-95B4D9D9-B179-477A-BC77-E4FAD443C782Q49554733-ECD4E269-2E95-4368-A37B-67247A884687Q55100805-C443DDD2-E2F3-46F6-A3CD-4FB1E529990FQ55438981-E17E93D1-DDBE-45FA-8040-04315E83CA8DQ58803252-DAE65957-3CFA-4DF6-8AC3-A9A181D75B14
P2860
The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The EQ-5D-5L health status que ...... d minimum important difference
@en
type
label
The EQ-5D-5L health status que ...... d minimum important difference
@en
prefLabel
The EQ-5D-5L health status que ...... d minimum important difference
@en
P2093
P2860
P1433
P1476
The EQ-5D-5L health status que ...... d minimum important difference
@en
P2093
Claire M Nolan
Jane L Canavan
Louise Longworth
Sarah E Jones
William D-C Man
P2860
P304
P356
10.1136/THORAXJNL-2015-207782
P407
P577
2016-03-30T00:00:00Z